אירינוטקן " אבווה, 20 מ"ג / מ"ל
pharmalogic ltd - irinotecan hydrochloride trihydrate 20 mg / 1 ml - concentrate for solution for infusion - irinotecan - irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.
"single use drapes and gowns,wound care,bandages"
"אורטה מדיקל בע""מ" - אחות - כיסויים חד פעמיים לכלל בית החולים ומרפאות
single use sterile and non sterile covers and devices
"ברסלויער בע""מ" - רופא
single use drapes and gowns,wound care,bandages
אורטה מדיקל בע"מ - אחות - כיסויים חד פעמיים לכלל בית החולים ומרפאות
single use sterile and non sterile covers and devices
ברסלויער בע"מ - רופא
single use surgical instruments
עינת מדיקל סוכנויות בע"מ - רופא - לניתוחים כללים ולניתוחי עיניים
single use laparoscopic products and single use products
נובוגולד בע"מ - אחות - מכשור לפרסקופי ואביזרים לחדר ניתוח חד פעמיים
single use laparoscopic & electro surgical instruments + accessories
טי. אם. אס. ספקה רפואית בע"מ - רופא
אוונקס תמיסה להזרקה
medison pharma ltd - interferon beta 1a - תמיסה להזרקה - interferon beta 1a 30 mcg / 0.5 ml - interferon beta-1a - interferon beta-1a - treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of mri abnormalities characteristic of ms and if they are determined to be at high risk of developing clinically definite multiple sclerosis. safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.